| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Giuffre Randall Michael is a Director at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $2.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 65,000 | $3.91 | $254,150.00 | +22.0% | -29.4% | -49.2% | |
| Dec 9, 2022 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 57,079 | $1.42 | $81,022.97 | +13.4% | +21.0% | +104.2% | |
| Dec 7, 2022 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 24,874 | $1.40 | $34,708.60 | +6.9% | +26.6% | +104.3% | |
| Dec 1, 2022 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 819 | $1.19 | $974.61 | +0.5% | +47.5% | +115.8% | |
| Dec 1, 2022 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 67,228 | $1.20 | $80,462.65 | +18.2% | +47.5% | +115.8% | |
| Nov 20, 2020 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 15,000 | $4.26 | $63,912.00 | +16.0% | - | - | |
| Dec 11, 2018 | DMAC Diamedica Therapeutics Inc. | Director | Buy | 11,250 | $4.00 | $45,000.00 | +15.1% | - | - |